Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Gene Mutations in Melanoma

March 28th 2019

Study Validates Speed, Accuracy of Liquid Biopsies Identifying NSCLC Biomarkers

February 28th 2019

A liquid biopsy test detected all of the guideline-recommended biomarkers in newly diagnosed patients with metastatic non–small cell lung cancer at a similar rate but faster turnaround time to that of tissue genotyping.

A Game-Changing Year for NSCLC

February 26th 2019

Available Therapies for ALK-Rearranged NSCLC

February 26th 2019

Resistance Mechanisms in EGFR+ NSCLC

February 26th 2019

Osimertinib, the Standard for EGFR+ NSCLC

February 26th 2019

Molecular Testing for NSCLC in 2019

February 26th 2019

ADRIATIC Trial in Locally Advanced Small-Cell Lung Cancer

February 26th 2019

A Win for Small-Cell Lung Cancer: IMPOWER 133

February 26th 2019

Treatment Options for mNSCLC After Progression

February 26th 2019

CheckMate-227 and the Role of TMB in NSCLC

February 26th 2019

Looking at the IMpower Data in NSCLC

February 26th 2019

Choosing Therapy for Newly Diagnosed NonDriver NSCLC

February 26th 2019

Driver Mutations Trump PD-L1 Expression in Lung Adenocarcinoma

February 26th 2019

Biomarker Testing in Stage III NSCLC

February 26th 2019

Imaging Schedule Following CRT in Locally Advanced NSCLC

February 26th 2019

The Role of Surgery in NSCLC Following PACIFIC Trial

February 26th 2019

Impact of PACIFIC Trial on Locally Advanced NSCLC

February 26th 2019

Process Gets Overlooked in the Obsession With Outcomes in Oncology

February 14th 2019

It is essential to appreciate that precision cancer medicine is a process, not an event.

Microbial Metabolomics: A Search for the Missing Link to Cancer

February 8th 2019

Thanks to technological advances, the past several decades have witnessed a blossoming appreciation of the varied composition of these microbial communities, their complex and dynamic relationship with the host, and the way they affect health and disease.